Arena Pharmaceuticals, Inc. (ARNA) Posts Q2 Loss of 12c/Share, Wider than Views
Tweet Send to a FriendGet Alerts ARNA Hot Sheet
Price: $7.98 -0.25%
Financial Fact:
Loss from operations: -21M
Today's EPS Names:
LBIX, ESEA, ISS, More
Financial Fact:
Loss from operations: -21M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade ARNA Now!
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reported Q2 EPS of ($0.12), $0.04 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $22 million versus the consensus estimate of $7.38 million.
For earnings history and earnings-related data on Arena Pharmaceuticals, Inc. (ARNA) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Arena Pharmaceuticals, Inc. (ARNA) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Cisco Systems (CSCO) Tops Q3 EPS by 2c; Gross Margin Widens
- Macy's (M) Posts Q1 EPS of 55c; Comps Up 3.8%; Boosts Dividend 25%, Raises Buyback
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
